View Item 

Show simple item record

Sepsis Syndrome and Associated Sequelae in Patients at High Risk for Gram‐Negative Sepsis
dc.contributor.authorConboy, Kathleenen_US
dc.contributor.authorWelage, Lynda S.en_US
dc.contributor.authorWalawander, Cynthia A.en_US
dc.contributor.authorDuffy, Linda C.en_US
dc.contributor.authorWelliver, Robert C.en_US
dc.contributor.authorZielezny, Maria A.en_US
dc.contributor.authorDiPiro, Joseph T.en_US
dc.contributor.authorRaebel, Marsha A.en_US
dc.contributor.authorGrasela, Thaddeus H.en_US
dc.date.accessioned2012-03-16T15:55:35Z
dc.date.available2012-03-16T15:55:35Z
dc.date.issued1995-01-02en_US
dc.identifier.citationConboy, Kathleen; Welage, Lynda S.; Walawander, Cynthia A.; Duffy, Linda C.; Welliver, Robert C.; Zielezny, Maria A.; DiPiro, Joseph T.; Raebel, Marsha A.; Grasela, Thaddeus H. (1995). "Sepsis Syndrome and Associated Sequelae in Patients at High Risk for Gram‐Negative Sepsis." Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 15(1). <http://hdl.handle.net/2027.42/90154>en_US
dc.identifier.issn0277-0008en_US
dc.identifier.issn1875-9114en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/90154
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleSepsis Syndrome and Associated Sequelae in Patients at High Risk for Gram‐Negative Sepsisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, University of Michigan, and Department of Pharmacy, University of Michigan Medical Center, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherCenter for Pharmacoepidemiology Research, State University of New York at Buffalo, Buffalo, New Yorken_US
dc.contributor.affiliationotherDepartment of Social and Preventive Medicine, State University of New York at Buffalo, Buffalo, New Yorken_US
dc.contributor.affiliationotherDepartment of Pediatrics, Children's Hospital of Buffalo, Buffalo, New Yorken_US
dc.contributor.affiliationotherDepartment of Pharmacy Practice, University of Georgia, and Medical College of Georgia, Augusta, Georgiaen_US
dc.contributor.affiliationotherDepartment of Clinical Pharmacy, Kaiser Permanente, Aurora, Coloradoen_US
dc.identifier.pmid7739948en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/90154/1/j.1875-9114.1995.tb04333.x.pdf
dc.identifier.doi10.1002/j.1875-9114.1995.tb04333.xen_US
dc.identifier.sourcePharmacotherapy: The Journal of Human Pharmacology and Drug Therapyen_US
dc.identifier.citedreferenceKnaus WA, Sun X, Nystrom O, Wagner DP. Evaluation of definitions for sepsis. Chest 1992; 101: 1656 – 62.en_US
dc.identifier.citedreferenceCenters for Disease Control. Nosocomial infection surveillance, 1983. MMWR 1984; 33 ( 2SS ): 9SS – 21.en_US
dc.identifier.citedreferenceCenters for Disease Control. Nosocomial infection surveillance, 1984. MMWR 1986; 35 ( lSS ): 17SS – 29.en_US
dc.identifier.citedreferenceManship L, McMillin RD, Brown JJ. The influence of sepsis and multisystem organ failure on mortality in the surgical intensive care unit. Am Surg 1984; 50: 94 – 101.en_US
dc.identifier.citedreferenceAnonymous. Increases in the national hospital discharge survey rates for septicemia, United States, 1979–1987. MMWR 1990; 39: 31 – 4.en_US
dc.identifier.citedreferenceBone RC. Gram‐negative sepsis. Background clinical features and intervention. Chest 1991; 100: 802 – 8.en_US
dc.identifier.citedreferenceParrillo JE, Parker MM, Natanson C, et al. Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113: 227 – 42.en_US
dc.identifier.citedreferenceNiederman MS, Fein AM. Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia. A common clinical sequence. Clin Chest Med 1990; 11: 633 – 56.en_US
dc.identifier.citedreferenceBalk RA, Bone RC. The septic syndrome. Definition and clinical implications. Crit Care Clin 1989; 5: 1 – 8.en_US
dc.identifier.citedreferenceQuintiliani R, Cooper B, Maderazo E, Nightingale C. Comparison of the efficacy, safety, and therapeutic usage of HA‐1A and E5 in the treatment of gram negative sepsis. Hosp Formulary 1992; 27: 49 – 59.en_US
dc.identifier.citedreferenceBone RC. Gram‐negative sepsis: a dilemma of modem medicine. Clin Microbiol Rev 1993; 6: 57 – 68.en_US
dc.identifier.citedreferenceMausner JS, Kramer S. Epidemiology—an introductory text. Philadelphia: WB Saunders, 1985: 167 – 8.en_US
dc.identifier.citedreferenceZiegler EJ, Fisher CJ Jr, Sprung CL, et al. Treatment of gram‐negative bacteremia and septic shock with HA‐1A human monoclonal antibody against endotoxin. A randomized, double‐blind, placebo‐controlled trial. N Engl J Med 1991; 324: 429 – 36.en_US
dc.identifier.citedreferenceWenzel R, Perl T, Bone R, et al. Results of a second double‐blind, randomized, controlled, trial of antiendotoxin antibody E5 in gram‐negative sepsis [abstr 1170]. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapeutics, Chicago, September 29-October 2, 1991.en_US
dc.identifier.citedreferenceGreenman RL, Schein RM, Martin MA, et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram‐negative sepsis. The XOMA study group. JAMA 1991; 226: 1097 – 1102.en_US
dc.identifier.citedreferenceConboy KA, Welage LS, Walawander CA, et al. Applying the updated definitions for sepsis in a population of patients at risk for gram‐negative sepsis. Crit Care Med 1994; 22: A114.en_US
dc.identifier.citedreferenceBone RC. Let's agree on terminology: definitions of sepsis. Crit Care Med 1991; 19: 973 – 6.en_US
dc.identifier.citedreferenceGrasela TH Jr, Schentag JJ. A clinical pharmacy‐oriented drug surveillance network. I. Program description. Drug Intell Clin Pharm 1987; 21: 902 – 8.en_US
dc.identifier.citedreferenceBone RC. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992; 268: 3452 – 5.en_US
dc.identifier.citedreferenceMcGowan JE, Barnes MW, Finland N. Bacteremia at Boston City Hospital: occurrence and mortality during 12 selected years (1935–1972 with special reference to hospital acquired cases). J Infect Dis 1975; 132: 316 – 35.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1875-9114.1995.tb04333.x.pdf
Size:
1.035MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.